To investigate the influences of lifestyle and metabolic syndrome (MetS) on the prevalence of benign prostatic hyperplasia (BPH) requiring treatment using a large historical cohort.
Introduction
Reportedly,~50% of adult men present with LUTS [1, 2] , and BPH is the most well-known cause for male LUTS [3] . Previous studies have shown that BPH causes deterioration in the patient's quality of life [4] and is associated with marked socioeconomic costs [5] . As the prevalence of BPH increases with age [6] , treatment for BPH has been rapidly increasing reflecting the growth in the ageing population and becoming a major medical concern. Therefore, prevention of BPH that requires medical and/or surgical treatment is gaining considerable attention.
Metabolic syndrome (MetS), which is closely related to the development of cardiovascular disease [7] , is another wellknown age-related condition [8] . Recently, several studies have reported an association between MetS and BPH [9, 10] . However, most of these were cross-sectional studies and more reliable data regarding the impacts of MetS on the prevalence of BPH requiring treatment are awaited, due to the rapidly increased medical costs for treating BPH as mentioned above [5] . Moreover, MetS comprises a cluster of abnormal metabolic findings; thus, the effect of each component of MetS on BPH requires closer evaluation.
Although the development of MetS is known to be affected by a complex interaction between numerous factors, lifestyle factors are known to play an important role in its development [11] . Additionally, a few studies have reported that lifestyle also affects the development of BPH [12] , and lifestyle modifications are recommended as a primary treatment strategy for the management of mild LUTS in both genders [13] . However, few studies have reported the influence of lifestyle on the prevalence of BPH concomitant with MetS or its components.
We investigated the influence of MetS and lifestyle on the prevalence of BPH requiring treatment using a large historical cohort obtained from the National Health Information Database of the National Health Insurance Service (NHIS) in South Korea. Because BPH and MetS are well-known agerelated diseases, we attempted to assess the influence of MetS and MetS components on the prevalence of BPH requiring treatment, whilst considering the effects of age. Additionally, we assessed the influence of lifestyle on the prevalence of BPH requiring treatment.
Patients and methods

Patient cohort
In South Korea, medical expenses are universally covered by the NHIS and >50 million persons are covered by the NHIS. We assessed the NHIS databases between 2003 and 2013, including~510 000 individuals [14] . These databases consist of a qualification database (including gender, age, residence, and income amongst other variables), a medical database (including the use of clinics, diagnosis, and medications amongst other variables), and a health screening database (including body mass index [BMI] , waist circumference, laboratory examinations, and questionnaires). From these databases, we selected 130 454 men who underwent health screening at 2009 (Fig. S1 ) because laboratory examinations required to define MetS had been included in national health screenings since 2009. After excluding 112 men in whom adequate information regarding MetS components was unavailable, we studied 130 342 men. This study was approved by the Institutional Review Board of our hospital and the NHIS.
Definitions
MetS was defined based on the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) guidelines [15] . All diseases were defined based on the Korean Classification of Diseases, sixth revision (KCD-6) codes, which was modified based on the International Classification of Diseases, 10th revision (ICD-10), the Anatomical Therapeutic Chemical classification system, and examination results included in the health screening database (Table S1) based on concomitant MetS and its components, the level of smoking (none vs ≤20 vs >20 pack-year) and the level of alcohol consumption (none vs ≤150 vs >150 g/week) was presented based on age categories. Before analysis, a square-root transformation was performed for the level of alcohol consumption because of its skewed distribution. A generalised estimating equation (GEE) was used to assess the variables that showed an association with the prevalence of BPH requiring treatment [16] . Similarly, the GEE was used to assess the impact of each component of MetS (based on age) on the prevalence of BPH requiring treatment after adjusting for the year at the time of evaluation, residence, income, and the levels of smoking and alcohol consumption. All statistical analyses were performed using the Statistical Analysis System (SAS) version 9.4.2 software (SAS Institute, Cary, NC, USA) and R version 3.4.2 (http://www.r-project.org). A P < 0.05 was considered statistically significant.
Results
Baseline characteristics
The percentage of men with MetS in their 40s, 50s, 60s, and 70s was 27.4%, 33.1%, 39.2%, and 40.6%, respectively Table 2 ). In men aged ≥50 years, the prevalence of BPH requiring treatment was significantly higher in men with MetS between 2009 and 2013. Amongst the components of MetS, decreased high-density lipoprotein cholesterol (HDL-C) was the only component that was significantly associated with the prevalence of BPH requiring treatment, regardless of age and year at the time of evaluation (Table S3) .
Correlation between the prevalence BPH requiring treatment and lifestyle
The prevalence of BPH requiring treatment in nonsmokers was significantly higher than in smokers aged <60 years, although there was no statistically significant difference in men aged ≥70 years (Table 3 ). The prevalence of BPH requiring treatment in nondrinkers was higher than in drinkers. The prevalence of BPH requiring treatment in drinkers was lower regardless of age, although the difference was not statistically significant in men aged ≥70 years. The prevalence of BPH requiring treatment in men belonging to low-income groups was significantly lower in men aged ≥60 years. P < 0.001; 70s: OR 1.403, P < 0.001) was associated with the prevalence of BPH requiring treatment in all age categories after adjusting for the year at evaluation, residence, income, levels of smoking and alcohol consumption ( Table 4 ). The level of alcohol consumption (50s: OR 0.988, P < 0.001; 60s: OR 0.978, P < 0.001; 70s: OR 0.974, P < 0.001) was negatively associated with the prevalence of BPH requiring treatment in all age groups except in the 40s. The level of smoking was negatively associated with BPH requiring treatment only in men the 40s age group (OR 0.997, P = 0.046). Low income was significantly associated with the prevalence of BPH requiring treatment in men aged ≥60 years (60s: OR 0.811, P < 0.001; 70s: OR 0.817, P < 0.001). Amongst the components of MetS, decreased HDL-C was the strongest predictor for BPH requiring treatment in all age categories and the only MetS-related component that was significantly associated with the prevalence of BPH requiring treatment in men in the 40s age group (Table 5) . However, every other MetS component was positively associated with the prevalence of BPH requiring treatment in men aged ≥50 years.
Discussion
With an ageing population that continues to grow globally [17] , utilisation of medical services for age-related disease, including MetS and BPH, has increased substantially. In this regard, there is greater interest in determining the association between MetS and BPH that requires treatment. Moreover, the role of lifestyle modifications in maintaining a healthier lifestyle, even in the ageing population, is being widely emphasised. However, very few studies have reported sufficient evidence regarding the impact of MetS and lifestyle on the prevalence of BPH. Considering the economic costs and time required for these studies, it might be difficult to perform prospective cohort studies to further analyse this topic. Thus, the present study involving a large historical cohort assumes significance until reliable prospective cohort studies are conducted. Furthermore, the present study is valuable in providing a deeper understanding of this subject because we evaluated the influence of each component of MetS on the prevalence of BPH requiring treatment.
Based on the present study, we found that MetS was significantly associated with an increased prevalence of BPH requiring treatment during the 5-year follow-up, regardless of age. Although similar results have been reported previously [18, 19] , the results of the present study are more reliable because of the large size of our study population. The results of the present study are supported by a previous study, which reported that MetS causes prostatic enlargement [20] . When the influence of MetS on the prevalence of BPH requiring treatment was compared based on age, the effect of MetS on the prevalence of BPH requiring treatment tended to increase with increasing age. These results could be related to the fact and strengthen the hypothesis that the influence of MetS on BPH is related to the duration of MetS in the patient. Thus, MetS diagnosed in older men would indicate a longer duration of the condition, indicating therefore a maximal impact of MetS on the prevalence of BPH requiring treatment in older men. However, this theory needs further validation.
Previously, each component of MetS has been reported to be associated with BPH [21] [22] [23] . However, the influence of a single component of MetS on the prevalence of BPH cannot be easily assessed because of intercomponent correlations. In the present study, although each component of MetS was associated with an increased prevalence of BPH requiring treatment, decreased HDL-C was the only component, which was significantly associated with the prevalence of BPH requiring treatment regardless of age. Although each MetS component showed detrimental effects on BPH, decreased HDL-C was the most powerful variable associated with the prevalence of BPH requiring treatment. A recent metaanalysis reported that a low HDL-C level was the most powerful variable associated with BPH amongst MetS-related variables [9] , which is in agreement with our present study results. Moreover, increasing HDL-C levels has been reported to reduce prostate size and improve LUTS [24] . These findings suggest that maintaining high HDL-C levels could be a particularly important preventive strategy that should be considered from a young age. Based on these results, urologists need to pay close attention to HDL-C levels when treating patients with BPH. Although hypertension (HTN) was marginally associated with the prevalence of BPH requiring treatment in men in the 40s age group, which was in contrast to the results of previous studies [22] , these results might be secondary to the fact that young males with HTN are more likely to pay close attention to their health and have better access to and utilisation of health care.
In the present study, weekly alcohol consumption showed a negative association with the prevalence of BPH requiring treatment regardless of age, which was similar to the results of previous studies [25, 26] . However, the impact of alcohol consumption on the prevalence of BPH requiring treatment needs to be interpreted with caution because the difference between the prevalence of BPH requiring treatment was significantly different only in 2009. Additionally, the increment in the prevalence of BPH requiring treatment during the 5-year follow-up was equivalent according to the alcohol consumption (data not shown). That is, our present results cannot support the preventive effects of alcohol on BPH, and we could only conclude that the prevalence of BPH requiring treatment increases with ageing, although it is slightly less prevalent in all age groups if they drank alcohol. In the present study, the level of smoking was found to be significantly associated with the prevalence of BPH, which is in agreement with previous studies [27] . Although the level of smoking was significantly associated with a decreased prevalence of BPH in men aged <50 years, this finding might be secondary to the fact that a close relationship exists between smoking and alcohol consumption, and this topic requires further validation. The present study showed that a low income was significantly associated with a decreased prevalence of BPH requiring treatment in men aged ≥60 years. Although this finding may be secondary to the indifference/neglect of health issues in elderly men with a low income and their limited access to medical/healthcare facilities, this result is hypothesisgenerating only, and the reason for these findings remain to be validated in a future study.
Limitations of our present study include: (i) the retrospective design was a shortcoming, although this historical cohort was followed-up for 5 years. (ii) A selection bias could have influenced our results because uninsured men and/or men who did not visit medical facilities despite symptoms could not be accurately assessed. Nevertheless, our study results could be considered reliable because of the large study population and 5-year follow-up with a small number of dropouts during the study period. (iii) The diagnosis of BPH could not be standardised and may be different depending on the clinician's preference and their specialty. (iv) The severity of BPH, which is usually assessed using TRUS and/or validated questionnaires, could not be evaluated in the present study, and the degree of BPH and/or LUTS could be widely variant within the patients with BPH requiring treatment. Finally, the results of the present study should be interpreted with caution. Because BPH requiring treatment has not been defined based on objective criteria, as mentioned above, the characteristics of the group with a high level of interest in health may appear as the variables associated with the increased prevalence of BPH requiring treatment, even though the treatment for bothersome BPH is less prevalent in this group.
In conclusion, MetS and its components, particularly decreased HDL-C, have a detrimental effect on the prevalence of BPH requiring treatment. In addition, moderate levels of alcohol consumption and elderly men from lower socioeconomic groups were associated with a lower prevalence of BPH requiring treatment in our present cohort. Preventing the development of MetS and maintaining optimal HDL-C levels could be important strategies for decreasing the prevalence of BPH requiring treatment and further studies are expected to be conducted to validate the results of the present study.
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